The Print on MSN
As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers
Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results